Registration of medicinal products for human use RAEFAR
Target persons
To the pharmaceutical laboratories to carry out the following procedures:
- Follow-up of New Drug Registration Applications (eAF+CESP)
- Follow-up of Requests for Variations on authorized medicines. (eAF+CESP)
- eAF Request for variation.
- Guidelines on the details of the various categories of amendments to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products(2013/C 223/01), Spanish version.
- eAF Request for Renewal.
- Consultation document for applicants.
The administrative procedures that can be performed through this application are as follows:
Code | Name of the Procedure | Object |
---|---|---|
080180 | Marketing authorisation for industrially manufactured medicinal products or other medicinal products for human use. | Obtain the authorization of marketing of medicines by the procedures of national, mutual recognition and decentralized. |
080190 | Suspension and revocation of the authorization of medicines. | Suspend or revoke the authorization of a drug “Extensions and Uprisings”. |
080210 | Authorisation of major variations in Type II medicinal products. (FOLLOW-UP). | Modify higher-importance specifications of an already authorized drug. |
080620 | Authorizations for minor variations in Type I A and Type I B Drugs. (FOLLOW-UP). | Authorise minor modifications of a medicinal product. |
202099 | Notifications about marketing of medicines. | |
202101 | Five-year revalidation. (FOLLOW-UP). | The Five-Year Revalidation of the Marketing Authorisation of the medicinal product taking into account scientific technical progress. |
202102 | Free samples. | Request for free samples of Medicines for those that do not contain psychotropic or narcotic drugs, that do not create dependency and are not qualified as special control. |
202103 | Modifications of Centralized. | Communication of centralized drug authorizations. More information in the information note (Submission of the application for national code and conditioning material through RAEFAR II for centrally authorised medicinal products). |
202104 | Request for Request for National Codes. | Request for National Codes of those products authorized by Mutual Recognition or Decentralized that have authorized the formats and that is thus included in the technical file. |
– | Telematic Management of Technical Data Sheet and Prospectus. | Telematic management of the technical data sheets and leaflets during the processes of authorisation of a new medicine (provided that it has obtained a favourable report from CODEM in the case of nationals, or when the translation phase has begun in the case of MRP) and of variation of the marketing authorisation that leads to a modification of the texts. |
– | Parallel Imports. | Solicitud de comercialización paralela de medicamentos de uso humano autorizados un medicamento autorizado en un Estado miembro (REAL DECRETO 11/2005). |
– | Non-Industrial Medicines. | Marketing authorization of medicines for human use Non-Industrial. |
– | Transfers. | (Request for Transfers 801, 802, 803 and 804). |
– | Notifications of Article 61.3. | Notifications of Article 61.3. |
– | Request for Centralized National Code (eAF). | Presentation of the application for the National Code and Conditioning Material for centrally authorised medicines. |
– | Application of Homeopathic. | Obtain the marketing authorization of homeopathic medicines. |
Documentation
- User’s guide for loading photographs of the pharmaceutical form, primary packaging and outer packaging of the drug in CIMA (Version 2.0 – June 2024)
- Guide “Sending electronic files to the AEMPS”. Sending and tracking by electronic records laboratories to the AEMPS
(Version 3.0 – August 2017) - How to complete eAF version 1.20 (English version)
- REGISTER AEMPS – USER MANAGEMENT – User Manual
- Manual of Fractionation of technical data sheet and prospectus with Word plugin. (version 5.5, July 2020)
- User manual of the web application for marketing notification of Medicines for Human Use. (version 5.1, 16 January 2019)
- RAEFAR II – AEMPS COMMON REGISTRY “Applicant Support Guide for the correct completion of applications for National Codes and Modifications of Centralized Medicines”. (Version 1.0)
- RAEFAR II – AEMPS COMMON REGISTRY “Applicant Support Guide for Correct Completion of Applications on Implementation of Safety Devices in Authorizations of Medicinal Products for Human Use”.(Version 1.0)
- RAEFAR II – AEMPS_Guide to support the applicant for the correct completion of applications on transfer of ownership and/or change of representative in the authorizations of medicines for human use». (Version 1.0)
- Applicant Help Guide for Creating/Managing Users and Superusers (SPOR Program)(Version 1.0)
Characteristics of the client teams
What authentication methods will be needed?
- Digital certificate
- Electronic ID
- Cl@ve PIN
- In some cases it will not be necessary to have any method of authentication
What characteristics do the client teams have to have?
- Next generation browser: Edge, Chrome, Firefox, Safari or similar.
- The use of Internet Explorer is not recommended.
- Any PDF document viewer. You can download the Adobe Acrobat Reader at the address http://www.adobe.com/.
- User authorization and password of RPS.
- Application security: activate the Java Script option in the browser if it is not active (this option comes by default).
Since it is a Web application, there are no operating system or memory or disk requirements beyond those necessary for the operating system, browser and PDF viewer chosen.
What are the security elements that the applications incorporate?
- 128-bit SSL communications encryption.
- User authentication using USER and password.
- Autenticación de usuario de segundo nivel, mediante TOKEN UNICO por solicitud que el usuario debe introducir para el envío de las mismas.
- Each external user can only access the data of the entity it represents.
- Log of accesses and audit of modifications (you know who modifies and what).
- Time out of connection.
Answers to frequently asked questions (FAQs)
Notification of errors
If you experience errors or difficulties with the application, please let us know by registering a request at the following link:https://servicedesk.aemps.es/servicedesk/customer/portal/2/.
Include as much information as possible about the incident, including screenshots, error messages, etc. To make it easier for our technicians to detect and resolve the problem.
Rates
For fee-related issues, if you experience errors or difficulties regarding the payment of fees, please let us know by registering an application at the following link:https://servicedesk.aemps.es/servicedesk/customer/portal/2/(Incidents – Application FEES).